Langerhans cells (LC) are sentinels of skin's immune system, their loss from epidermis 29 contributing to UVR-suppression of cell mediated immunity (CMI). Omega-3 polyunsaturated 30 fatty acids can show potential to abrogate UVR-suppression of CMI in mice and humans, 31 potentially through modulation of LC migration. Our objectives were to examine if 32 eicosapentaenoic acid (EPA) ingestion influences UV-mediated effects on epidermal LC 33 numbers and levels of immunomodulatory mediators including prostaglandin (PG)D 2 , which 34 is expressed by LC. 35
1 reduced cutaneous PGD 2 levels in humans, starkly contrasting with reported effects of UVR
Introduction 53
Ultraviolet radiation (UVR) suppresses cutaneous immunity (photoimmunosuppression) and 54 this is believed to be an important contributor to the development of skin cancers [1] . In 55 addition to the mutagenic effects of UVR on DNA which initiate carcinogenesis, inhibition of 56 cell mediated immunity (CMI) can allow cancerous cells to escape destruction by cytotoxic 57 lymphocytes, facilitating tumour progression. This has been elegantly demonstrated in 58 mouse models where antigenic tumour cells were transplanted into UVR-exposed mice 59
where they were able to progress [2] . Moreover, immunosuppressed patients have a higher 60 incidence of skin malignancies [3] . 61
Dendritic cells, including epidermal Langerhans cells (LC) and dermal dendritic cells 62 (DC), are antigen presenting cells (APC) and are amongst the first line of defence in the skin 63
where they facilitate innate and adaptive immunity and promote antigenic tolerance [4, 5] . 64
The LC reside above the basal layer of the epidermis and monitor the skin microenvironment 65 for danger signals including pathogens, chemicals and tumour peptides. On capturing 66 antigenic material they travel along the afferent lymphatics to the skin-draining lymph nodes 67 (DLN) and activate differentiation of naïve T cells (Th-0) into T helper (Th)-1, Th-2, Th17, 68
Th22 or Treg cells [5] . Following UVR-exposure LC migrate away from the epidermis [6] , and 69 their behaviour is altered, favouring activation of Th-2 immune responses and Treg cells 70 over Th-1 driven CMI [7] [8] [9] [10] ; these changes are believed to contribute to UVR-induced 71 suppression of skin immunity [11] . This can be observed clinically by diminished skin contact 72 hypersensitivity (CHS) and delayed type hypersensitivity responses to allergens following 73 UVR-exposure [12] . 74
The response of LC and other dendritic cells to antigen are strongly influenced by 75 signals in the skin microenvironment. Cytokines TNF-α and IL-1β stimulate LC migration 76 from the epidermis after exposure to antigen [13, 14] , and both are upregulated in the skin in 77 response to UVR-exposure. UVR also upregulates further cytokines possessing pro-78 inflammatory (including IL-8, IL-6 and IFN−γ) and immunosuppressive (including IL-4 and IL-79 4 4 10) properties [15, 16] . Moreover, prostaglandins (PG) produced in the skin are reported to 80 regulate dendritic cell activity. PGE 2 can modulate LC migration and maturation in mice [17] 81 and reduces the ability of bone marrow derived dendritic cells to stimulate a CMI responses 82
following UVR-exposure [18] , indicating a potential influence on antigen presenting activity 83 during photoimmunosuppression. Interestingly, it has also been reported that human LC and 84 dermal dendritic cells express hematopoietic PGD synthase (hPGDS) supporting these cells 85 as a source of PGD 2 in the skin, alongside mast cells and keratinocytes [19] . A role for PGD 2 86 in photoimmunosuppression has not been explored but in murine skin and lung epithelia 87 PGD 2 inhibits dendritic cell migration and stimulation of T cell responses [20, 21] . 88
The omega-3 polyunsaturated fatty acid (n-3 PUFA) eicosapentaenoic acid (EPA) 89 reduces UVR-suppression of CMI in vivo; in mice, both topical and systemic EPA-rich lipids 90 reduced UVR-suppression of chemically induced CHS responses by up to 90% [22, 23] . 91
Further, we recently observed in a randomised controlled trial (RCT) in humans that oral 92 EPA supplementation showed potential to reduce UVR-UVR suppression of nickel CHS 93
[24]. While the mean group difference for the 3 solar simulated radiation (SSR) doses we 94 employed showed no statistically significant protection by EPA, ~50% reduction of 95 photoimmunosuppression was noted with UVR dosing equivalent to brief exposure to 96 summer sunlight (post-hoc analysis p<0.05) [24] . EPA exhibits a range of activities that may 97 contribute to protective profile, including transcriptional activation of cytokine genes and 98 modulation of PG synthesis [25] . EPA competes with the n-6 PUFA arachidonic acid (AA) for 99 metabolism by cyclooxygenase (COX) enzymes, and this can reduce the levels of AA-100 derived PG [26] . 101
In a double-blind RCT in 79 females, the objective of the current study was to explore 102 the impact of dietary EPA on epidermal LC numbers as a potential mechanism of abrogation 103 of photoimmunosuppression, and to examine for influence on levels of immunomodulatory 104 mediators. Cutaneous samples were taken from UVR-exposed and unexposed skin pre-and 105 post-a 12-week course of supplementation, with immunofluorescence assessment of 106 CD1a+ cells in epidermal sheets and quantification of PG and cytokines in blister fluid. immunosuppression study, reported elsewhere [24] ). Exclusion criteria: taking n-3 PUFA 114 supplements or photoactive medication, pregnancy or breast feeding, sunbathing or sun 115 bed use in the prior 3 months, history of photosensitivity, skin cancer or atopy. They did not 116 have active contact dermatitis at the time of the study. Written informed consent was 117 provided by all volunteers before study inclusion. Ethical approval was granted by North 118
Manchester local research ethics committee (08/H1006/30) and the study was performed 119 in accordance with the Declaration of Helsinki principles (revised Seoul 2008) . 120 121
Study Design and Intervention 122
The double-blind randomised (1:1) controlled parallel-group study took place in the 123 Photobiology Unit, Dermatology Centre, Salford Royal Hospital (Manchester, UK). 124
Treatment allocation sequence was permuted block design (mixed blocks of 4 to 6) and 125 produced by the study biostatistician using statistical software (v2.7.7; StatsDirect Ltd, 126 Altrincham, UK). Encapsulated active and control lipid supplements, identical in 127 appearance, were packaged and labeled according to the allocation sequence by GP 128 solutions Ltd (Manchester, UK), and the code held by the study biostatistician until study 129 completion. All volunteers and researchers were blinded and volunteers were assigned the 130 intervention on study enrolment and concurrently randomised to have either suction blister 131 6 6 compliance with supplementation was confirmed through measurement of red blood cell 135 (RBC) EPA levels (reported in [24] ). The parameters assessed here were secondary 136 outcome measures in a larger clinical trial of oral EPA supplementation that primarily 137 assessed impact on clinical photoimmunosuppression (nickel CHS; reported in [24] ). 138
Procedures in the different studies involved UVR-exposure to small skin areas only, at 139 separate body sites and times, with the CHS study performed post-supplementation after 140 completion of the current study. The n-3 PUFA supplements were 1g gelatine capsules 141
containing Incromega E7010 SR ethyl ester (~70% EPA and 10% DHA; Croda Chemicals 142
Leek Ltd, Staffordshire, UK). Control supplements comprised 1g gelatine capsules of 143 identical appearance containing glyceryl tricoprylate coprate (GTCC; Croda Chemicals 144
Leek Ltd), a medium chain triglyceride found in coconut oil, and previously used as control 145 oil in human supplement studies [27] [28] [29] . Both supplements were taken 5 capsules daily 146 with breakfast for 12 weeks. 147
148

UVR-exposure and Skin Sampling 149
All volunteers were exposed to broadband UVR (270-400nm, peak 310nm; 44% UVB, 56% 150 UVA, 1% UVC; TL12, Philips GmbH, Hamburg, Germany or UV21, Waldmann Co., VS-151 Schwenningen, Germany). Lamp irradiance was monitored during each exposure using 152 radiometers (Medical Physics Department, Dryburn Hospital and Waldmann IL730A, 153
International Light, Newburyport, USA) traceable to the UK National Physical Laboratory. 154
The individual's minimal erythemal dose (MED) was determined on study enrolment. Pre 155 and post-supplementation, upper buttock sites were exposed to 4x the individual's MED. 156
After 24h, skin suction blistering and skin punch biopsy were performed from UVR-157 exposed and unexposed sites (methods as described in [30] ). The 4x MED dose was 158 chosen to provide a sufficient challenge to produce quantifiable increases in cytokine and 159 eicosanoid expression in human skin in vivo [31, 32] . 
Epidermal Langerhans Cell Counting 163
Skin punch biopsies (5mm) from unexposed and UVR-exposed sites were immediately 164 placed in 0.02M ethylene diamine tetra acetic acid (EDTA) in phosphate-buffered saline 165 (PBS). After 2h incubation at 37 o C, epidermis was carefully peeled from dermis using 166 forceps. Epidermal sheets were washed in PBS, fixed in ice-cold acetone (20 minutes) and 167 re-washed in PBS, prior to incubation with mouse CD1a monoclonal primary antibody 168 (clone NA1/34; IgG2a (Dako, Stockport, UK)) diluted to 10µg/ml in PBS (0.1 % bovine 169 serum albumin (BSA; Sigma-Aldrich, MO, USA) and with fluorescein isothiocyanate (FITC) 170 conjugated goat anti-mouse secondary antibody (Dako; 1/100 in PBS (0.1% BSA)), before 171 mounting in Citifluor media (Citifluor, London, UK). LCs were counted using an Olympus 172
Bx50 fluorescence microscope fitted with an eyepiece graticule at 40x magnification. Fifty 173 fields per graticule were counted for each epidermal sheet. 174 175
Suction Blister Fluid Prostaglandin Measurement 176
Lipidomic analysis by mass spectrometry was performed as described previously [33, 34] . 177
In summary, blister fluid eicosanoids (50-200µl) were extracted in methanol-water (15% 178 wt/wt) and internal standard PGB 2 -d4 (40ng) (Cayman Chemicals, Ann Arbor, MI, USA) 179 was added. The extract was acidified to pH3.0 and applied to preconditioned solid-phase 180 extraction (SPE) cartridge (C18-E 500 mg, 6 mL) (Phenomenex, Macclesfield, UK) and 181 eluted with methyl formate. Chromatographic analysis was performed on a C18 column 182 (Luna, 5µm, 2.0mm, Phenomenex, Macclesfield, UK) using HPLC (Alliance 2695, Waters, 183
Elstree, Hertfordshire, UK) coupled to a triple quadrupole mass spectrometer with 184 electrospray ionisation (ESI) (Quattro Ultima, Waters). Multiple reaction monitoring 185 transitions were used to assay for the presence of PGD 2 (m/z 351 >271) and its 186 metabolites PGJ 2 , ∆ 12 -PGJ 2 (m/z 333 >271) and 15-deoxy-∆12,14 PGJ 2 (m/z 315 >271). 187
Results are expressed as pg/µl of blister fluid, based on calibration lines constructed from 188 commercially available standards (Cayman Chemicals). 189 190 8 8
Suction Blister Fluid Cytokine Measurement 191
A panel of cytokines (IL-8, IFN-γ, TNF-α, IL-1β, IL-4, IL-10, IL-23 and IL-17) was 192 simultaneously quantified in suction blister fluid using the Bio-Plex TM cytokine array system 193 (Bio-Rad Laboratories, Hercules, CA, USA) in accordance with manufacturer's instructions, 194 as described previously [35] . 195
Statistical analysis 196
The study was powered to detect a difference in clinical photoimmunosuppression 197 responses between EPA and control supplemented groups, as previously detailed [24] . were performed to make within-group comparisons between unexposed and UVR-exposed 202 skin. A p value of <0.05 was considered statistically significant. Results 218
Volunteers and compliance 219
Seventy-nine volunteers were recruited and randomised to the oral intervention: 6 did not 220 proceed to take supplements and discontinued the study for personal reasons; no data was 221 collected from them. Of the 73 who took supplements, 33 were randomised to control and 222 40 to EPA; baseline characteristics are shown (Table 1 ). Baseline dietary intake assessed 223 by food frequency questionnaire was below current UK recommendations of 450mg/day total 224 long chain n-3 PUFA [36, 37] . The EPA supplement was bioavailable in both RBC and skin 225 (p<0.001) as previously reported [30] . Three volunteers in the EPA group (all suction blister 226 subgroup) who showed no increase in RBC EPA levels post-supplementation were excluded 227 from analyses for poor compliance (Fig 1) . One individual in the EPA group declined 228 biopsies post-supplementation and data was excluded from analyses. Of the remaining 69 229 volunteers, 33 were in the control and 36 in the EPA group (Fig 1) . No adverse effects were 230 reported for either supplement. 231 232
Langerhans cells 233
To assess the effect of UVR exposure on epidermal LC density pre-supplementation, 234 baseline data of the two supplement groups was combined. UVR challenge produced a 235 reduction of ~65% in mean (SEM) LC number in the epidermis at 24 hours post-exposure, 236 from 920 (28) to 318 (39) per mm 2 (p<0.001) (Fig 2A) . Following supplementation, the UVR-237 induced reduction in LC number was similar to baseline for both control (881 (46) to 218 (44) 238 cells per mm 2 ; p<0.001) and EPA group (856 (55) to 191 (26) cells per mm 2 ; p<0.001), 239 decreases of 75% and 78%, respectively (Fig 2A) . There was no significant difference in 240 epidermal LC numbers between control and EPA groups post-supplementation, in 241 unexposed or UVR-exposed skin. Visualisation of LC in epidermal sheets revealed that 242
following UVR the majority of LC lost their dendritic projections and appeared in a more 243 rounded, migratory form. There was no apparent effect of EPA on LC morphology ( Fig 2B) in 244 unexposed or UVR-exposed skin. 245 10 10 246 Prostaglandin production 247 PGD 2 and its metabolites PGJ 2, ∆ 12 -PGJ 2 and 15-deoxy-∆12,14 PGJ 2 were measured in skin 248 blister fluid to explore impact of UVR and EPA; ∆ 12 -PGJ 2 was detected but below the limit of 249 quantitation and 15-deoxy-∆12,14 PGJ 2 was below limit of detection. At baseline, data from 250 both supplement groups was combined to examine effect of UVR exposure. 251 252 PGD 2 : At baseline, median (IQR) PGD 2 was decreased in UVR-exposed versus unexposed 253 skin (from 8.1 (11.6) pg/µl to 5.1 (5.6) pg/µl; p<0.001) ( Fig 3A) . Post-supplementation, 254 control group PGD 2 level was similarly decreased in UVR-exposed versus unexposed skin 255 (from 8.6 (6.3) to 4.1 (4.7) pg/µl; p<0.01). In contrast in the EPA group post-256 supplementation, no statistically significant reduction in PGD 2 occurred post-UVR. 257
Comparison of groups post-supplementation revealed that in unexposed skin PGD 2 was 258 ~40% lower in the EPA-unexposed versus control group (5.2 (4.8) vs 8.6 (6.3) non-259 significant), while in UVR-exposed skin, levels were similar (4.0 (5.3) vs 4.1 (4.7) pg/µl in 260 control group). 261 262 PGJ 2 : At baseline, PGJ 2 was significantly increased in UVR-exposed versus unexposed skin 263 (from 1.2 (1.3) to 2.1 (2.0); p<0.05) ( Fig 3B) . Post-supplementation small apparent increases 264 in PGJ 2 were seen in UVR-exposed skin in control and EPA groups (non-significant). There 265 were no significant differences in PGJ 2 levels between control and EPA groups post-266 supplementation. 267 268
Cytokine expression 269
Of the panel of cytokines assessed, IL-10, TNFα and IL-8 were quantifiable. Whilst IFN-γ 270 was detected, levels were below the limit of quantitation, and IL-1β, IL-4, IL-17 and IL-23 271
were not detected. Due to low blister fluid volumes, five individuals (two in EPA group and 272 three in control group) were excluded from cytokine analyses, resulting in n=16 for the 273 control and n=15 for the EPA group. IL-10 levels for two individuals in the control group were 274 out of range and excluded, resulting in n=14 in the control group. Baseline data for EPA and 275 control groups were combined to assess effect of UVR on cytokine levels pre-276 supplementation. 277 278 IL-8: At baseline, median (IQR) IL-8 increased in UVR-exposed versus unexposed skin 279 (791.9 (798.9) vs 238.1 (314) pg/ml; p<0.001; Fig 3D) . Similarly, post-supplementation, a 280 statistically significant UVR-induced rise in IL-8 was seen in the control group (from 162.3 281 (304.2) to 827.1 (443) pg/ml; p<0.001) and EPA group (from 244.5 (277. 3) to 591.7 (970.9) 282 pg/ml; p<0.01). There was no significant difference in IL-8 concentration in unexposed or 283 UVR-exposed skin in control versus treatment groups post-supplementation. 284 285 IL-10: At baseline, median (IQR) IL-10 concentration apparently increased following UVR 286 exposure, but this was not statistically significant (82 (153) vs 68.3 (142) pg/ml; Fig 3E) . 287
Similarly post-supplementation, there was an apparent increase in IL-10 concentration post-288 UVR in the control (90.3 (142) vs 79.6 (98) pg/ml) and EPA groups (95.8 (148) vs 70 (115) 289 pg/ml). There was no significant difference in IL-10 concentration in unexposed or UVR-290 exposed skin when comparing control and EPA groups post-supplementation. 291 292 TNFα: At baseline, median (IQR) TNFα concentration was not significantly altered in UVR-293 exposed versus unexposed skin (67.2 (98.5) pg/ml vs 57.7 (101.8) pg/ml) at baseline (Fig  294   3F ). Post-supplementation, there were apparent rises in TNFα in UVR-exposed versus 295 unexposed skin, in control (84.8 (107.2) vs 54.7 (139.7)) and EPA (88.1 (149.9) vs 36.6 296 (66.2)) groups (both non-significant). There was no significant difference in TNFα 297 concentration in unexposed or UVR-exposed skin when comparing control and EPA groups In this study UVR exposure of human skin in vivo at baseline (pre-supplementation) 302 significantly reduced epidermal LC density and altered the morphology of remaining LC, in 303 association with a notable reduction in PGD 2 . This significant UVR impact on PGD 2 304 production ( Fig 3A) is in stark contrast to the well-described increase in skin PGE 2 and other 305 eicosanoids examined following UVR-exposure to humans in vivo [30, 31] , and this could 306 have implications for health, including during sun-exposure and for the phototherapy of skin 307 disorders. The subsequent investigation of the impact of 12 weeks EPA supplementation 308 employed a robust study design and adequate sample size, and importantly, oral EPA 309 compliance and skin bioavailability was demonstrated in these volunteers [24, 30] . No 310 impact of EPA supplementation versus control was found on epidermal LC numbers, either 311 in unexposed or UVR-exposed skin, and hence we found no evidence that EPA abrogates 312 UVR-suppression of skin immunity through this mechanism in humans. 313 UVR induced loss of LC from the epidermis contributes to local UVR-induced 314 immunosuppression of the skin, which is partially mediated through induction of T-reg [11] . 315
Langerhans cell loss from the epidermis can be stimulated by a range of UVR doses, with 316 LC cell density and size reduction occurring in a UVR-dose dependent manner [38, 39] . We 317 observed a notable reduction in epidermal LC number of ~65% following a pro-inflammatory 318 (4xMED) UVR exposure. This magnitude of response is in line with a previous report in 319 human skin, where LC apoptosis in the epidermis was barely detectable after a very high 320 (6xMED) UVR challenge, while migration was observed [6] , supporting that the UVR-induced 321 epidermal loss of LC observed in our study could be due to migration. The current study 322 provides substantially the largest dataset to-date examining UVR-induced reduction in LC 323 number in human epidermis. Consistent with previous observations [40, 41] , notable inter-324 subject variation was seen in LC numbers under all treatment conditions. 325
While most skin blister fluid cytokines assessed in our study were below the assay 326 detection limit, the chemokine IL-8 showed a large induction in response to 327 in keeping with previous studies [16, 32] . TNF-α and IL-β are key cytokines involved in LC 328 13 13 mobilisation following exposure to UVR [13, 42] , however, IL-1β was not detected and while 329 TNF-α was present, no significant UVR-induced increase was found in blister fluid. A major 330 source of UVR-induced TNF-α is purported to be basal keratinocytes [43] , where UVR-331 induced nuclear DNA damage may stimulate its release [44] . The dermal neutrophil infiltrate, 332
which is reported to peak from 14 hours post-UVR may also contribute to TNFα increase 333
[45]. The immunosuppressive cytokine IL-10 inhibits dendritic cell IFN-γ production and 334 initiation of CMI responses and induces tolerance [46] [47] [48] . In UVR-irradiated human skin, IL-335 10 is reported to be preferentially induced in infiltrating CD11b+ macrophages which peak in 336 the dermis during the first 24 hours and in epidermis at 72 hours [49] ; as blister fluid is 337 primarily of epidermal origin [34] this might contribute to lack of significant IL-10 increase 338 observed in this study. No effect of EPA on cytokine levels was observed. A 24 hour post-339 UVR time point was selected as the most appropriate for assessing cytokines and 340 prostaglandins simultaneously [16, 31] , however, other time points might reveal differences. 341
We previously reported the skin PGE 2 level in this group of individuals was 342 augmented at 24 hours post UVR challenge [30] . PGE 2 stimulates IL-10 production in mouse 343 and human model systems, favouring a Th2 response, Treg activation and immune-344 suppression [15, 50, 51] . In contrast to the 127% rise in PGE 2 , we found skin PGD 2 levels in 345 the same volunteers were significantly reduced by 37% after UVR-exposure ( Fig 3C) . PGD 2 346 is associated with allergic inflammatory disorders in the respiratory tract [52] and skin [53] , 347
including mast cell disorders [54] and atopic dermatitis [55, 56] , and has potential relevance 348 to the novel treatment of other conditions featuring raised cutaneous PGD 2 , including hair- metabolites, in particular 15-deoxy-∆ 12,14 -PGJ 2 , reportedly exert anti-inflammatory effects 355
[59]. Further assessment of these metabolites in cutaneous inflammation could be valuable. 356
In human skin, LC, mast cells and dermal dendritic cells are primary sources of PGD 2 357
[19]. Post UVR-exposure of human skin, mast cell infiltration and degranulation occurs as 358 early as 4 hours post-challenge, but by 24 hours mast cell numbers and activity have 359 returned to normal [60], while epidermal LC are depleted. We propose that the UVR-360 reduction in cutaneous PGD 2 could partially reflect loss of LC from the epidermis. This is 361 supported by our observation of no UVR-induced PGD 2 reduction in human primary 362 keratinocytes and fibroblasts (unpublished data), or in the dermal fraction of human skin [61] . 363
In mice ageing-associated increases in local PGD 2 correlate with impaired migration of 364 respiratory DC, and antagonism of the DP1 receptor restores migration [16] . Constitutive 365 levels of PGD 2 may provide an inhibitory signal to migration which can be downregulated by 366 UVR. While we did not find an effect of EPA on PGD 2 levels in UVR-exposed skin, an 367 apparent fall in unexposed skin compared to control ( Fig 3A) was consistent with in vitro 368 findings of EPA reduction of PGD 2 production in niacin-stimulated human LC [62] . 369
Our recently reported assessment of a clinical CHS end-point in the same volunteers 370 suggested that 12 weeks oral EPA supplementation has the potential to reduce UVR-371 suppression of nickel CHS [24] . However, we have found EPA to have no impact on LC 372 number in unexposed and UVR-exposed skin when compared to the control group, when 373 using a high UVR-dose sufficient to produce a measurable increase in PG [30, 31] Thus, our 374 study did not support the mediation of immune-protective effects of EPA by changes in the 375 numbers of epidermal LC, although it is conceivable there may still have been changes in LC 376 activity. EPA may potentially exhibit greater protection with UVR at lower doses or different 377 spectra. This could be addressed in future studies, alongside examination of impact on other 378 DC subsets as understanding of their significance in human skin immunity becomes better 379 understood. 380
In conclusion, our double blind RCT did not find evidence for an impact of oral EPA 381 on UVR-induced reduction of epidermal LC. The significant UVR-induced fall in PGD 2 level 382 may have an immunomodulatory effect of relevance to the phototherapy of skin disease, and 383 warrants further investigation. 384 385 Acknowledgements 386 LER, NKG and PSF designed the study, SMP, PC, SPB and KAM performed the study and 387 data analysis, AN contributed essential equipment and reagents, SMP and LER wrote the 388 paper and PSF and AN critically revised the paper. We acknowledge the Association of 389
International Cancer Research for funding this study. We thank Rebecca Dearman and Ian 390
Kimber in the Faculty of Life Sciences at the University of Manchester for use of their 391
Luminex analyser, Donald Allan for technical support, Croda Chemicals Ltd for freely 392 supplying the active and control lipid supplements and GP solutions Ltd for packaging the 393 supplements. We also thank all the volunteers who took part in the study. 394 395
Conflict of Interests 396
The authors have no conflicts of interest. 397 (85) HRT/OCP 3 (no./total (%)) 2/33 (6) 6/40 (15) 1 BMI data from n=31 in the EPA group and n=31 in the control group 
